Skip to main content
OpenTrials
Completed

NCT Number: NCT04304937

Validation of Swedish Short PROM för Venous Insufficiency

Validation of a new short Swedish patient reported outcome measure for superficial venous insufficiency. Analysis of its capacity to measure quality of life and its responsiveness to change caused by treatment.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Karlskoga venöst centrum, Karlskoga, Sweden

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • agrees to participate, diagnosed with superficial venous insufficiency C2-C6

Exclusion criteria

  • does not want to participate, less than C2, does not submit the answered questionnaires

Treatment and study plan

Patient reported outcome measure

Other

2 questionnaires are tested against each other

Primary outcomes

  1. the short PROM is valid for measurement of quality of life and detects change caused by treatment

    Time frame: baseline and 8 weeks

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Collaborators

  • Skandinaviska Forskningsstiftelsen för Åderbråck och andra Vensjukdomar

Registry information

Official study title

Validation of a Swedish Version of a Short Patient-Reported-Outcome-Measure for Superficial Venous Insufficiency

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 12, 2020
Registry last updated
Mar 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.